TANG KEVIN bought AUPH

February 27, 2026 · Form 4 insider transaction

TANG KEVIN bought 300,000 shares of Aurinia Pharmaceuticals Inc. at $13.90 per share, a transaction worth $4.17M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
300,000
Price
$13.90
Total value
$4.17M
InsiderTANG KEVIN
RoleOfficer, Director, 10% owner
SecurityCommon Shares
Transaction codeP: Open-market purchase
Transaction dateFebruary 27, 2026
Filing dateMarch 3, 2026
Shares owned after11,629,500
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

The prices reported are weighted-average prices. These shares were purchased in multiple transactions at prices ranging from $13.51 to $14.23. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the SEC staff, upon request, all information regarding the number of shares purchased at each price within the ranges set forth in Footnotes 1 and 3 through 7.; Tang Capital Partners, LP ("TCP") beneficially owns 6,990,461 shares and Tang Capital Partners International, LP ("TCPI") beneficially owns 5,239,039 shares. Kevin Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP and TCPI. Mr. Tang has a pecuniary interest in the shares beneficially held by TCP and TCPI.

View the original Form 4 on SEC EDGAR